Home/ Supplements/ Omega 3/ DHA/EPA Capsule

DHA/EPA Capsule

product on market Capsule Women's Choice Pharmaceuticals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Docosahexaenoic Acid and Eicosapentaenoic Acid are omega-3 fatty acids with strong evidence supporting their roles in cardiovascular and cognitive health. These ingredients contribute to the maintenance of healthy cell membranes and inflammatory responses. However, the overall evidence coverage for this specific product profile is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for DHA/EPA Capsule
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Fat/Fatty Acid
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Vitamin E Gelatin Glycerin purified Water
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Dosage and Administration: Nestabs DHA - One tablet and one soft gel capsule daily or as directed by a physician.

Warnings & Precautions

Contraindications: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Warnings: Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.

If you are pregnant, nursing, or taking any medications consult your doctor before use.

Discontinue use and consult your doctor if any adverse reactions occur.

Not intended for use by persons under the age of 18.

Formulation Notes

Nestabs DHA Prenatal Multi-vitamin/Mineral Tablets with DHA and Choline

Indications and Usage: Nestabs DHA is indicated to provide vitamin/mineral and omega-3 fatty acid supplementation to women throughout pregnancy, during the postnatal for both lactating and nonlactating mothers. Nestabs DHA is also beneficial in improving the nutritional status of women prior to conception.

How Supplied: Nestabs DHA tablets for oral administration are supplied as six child-resistant blister cards containing 5 tablets and 5 softgel capsules each (NDC # 50967-317-30).

A prenatal powerhouse

Multi-vitamin/mineral tablet + DHA/EPA capsule

Gluten free

Description: Nestabs DHA combination tablet-capsule for oral administration is a light pink capsule-shaped film coated tablet with a pleasant sweet flavor with WC001 imprinted on one side of the tablet and a enteric coated light amber soft gel capsule omega-3 fatty acid containing both DHA and EPA.

Additional Information

Store at controlled room temperature 15 degrees - 30 degrees (59 degrees - 86 degrees F)

RX only

NDC 50967-317-30 (30 count) 6 blister cards; each containing 5 tablets and 5 capsules

Womens Choice Pharmaceuticals A division of ITF Pharma

Metadata

Product Details

UPC / SKU3 50967 31730 8
DSLD Entry Date2020-12-26
Product TypeFat/Fatty Acid
FormCapsule
DSLD ID241428
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.